From
Dr. Alberto Tozzi
Gaps and Opportunities of Artificial Intelligence Applications for Pediatric Oncology in European Research: A Systematic Review of Reviews and a Bibliometric Analysis.
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Oct 2026 · 1 min read
In brief
In brief
Systematic review examining the current state of artificial intelligence applications in pediatric oncology across European research. Identifies gaps in AI implementation and highlights opportunities for advancing machine learning tools in childhood cancer diagnosis, treatment planning, and clinical decision support.
Written by the GCMD Library team from the article.
The application of artificial intelligence (AI) systems is emerging in many fields in recent years, due to the increased computing power available at lower cost. Although its applications in various branches of medicine, such as pediatric oncology, are many and promising, its use is still in an embryonic stage. The aim of this paper is to provide an overview of the state of the art regarding the A…
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Article
A cohort study of a tailored web intervention for preconception care.
Alberto Tozzi · Published Oct 2026
Podcast
Le funzioni e gli usi dell'intelligenza artificiale per la salute
Alberto Tozzi · 14 min · Published Oct 2026
Article
[Obesity and cardiovascular risk in children].
Alberto Tozzi · Published Oct 2026
Article
Hepatitis B immune memory in children primed with hexavalent vaccines and given monovalent booster vaccines: an open-label, randomised, controlled, multicentre study.
Alberto Tozzi · Published Oct 2026
Article
Towards learning healthcare systems in Italy: opportunities and challenges of AI at point-of-care.
Alberto Tozzi · Published Oct 2026
Podcast
Data to impact: connecting the future of European pediatrics with Alberto Tozzi
Alberto Tozzi · 20 min · Published Oct 2026
